Grade 3 or 4 adverse events reported in more than 10% of all patients treated (safety population; N = 222)
| Adverse event, no. (%) . | Grade 3 . | Grade 4 . | Grade 3 or 4 . |
|---|---|---|---|
| Neutropenia | 91 (41) | 42 (19) | 133 (60) |
| Thrombocytopenia | 63 (28) | 23 (10) | 86 (39) |
| Anemia NOS | 37 (17) | 7 (3) | 44 (20) |
| Pneumonia NOS | 22 (10) | 5 (2) | 27 (12) |
| Fatigue | 26 (12) | 1 (1) | 27 (12) |
| Adverse event, no. (%) . | Grade 3 . | Grade 4 . | Grade 3 or 4 . |
|---|---|---|---|
| Neutropenia | 91 (41) | 42 (19) | 133 (60) |
| Thrombocytopenia | 63 (28) | 23 (10) | 86 (39) |
| Anemia NOS | 37 (17) | 7 (3) | 44 (20) |
| Pneumonia NOS | 22 (10) | 5 (2) | 27 (12) |
| Fatigue | 26 (12) | 1 (1) | 27 (12) |
NOS indicates not otherwise specified.